Publications by authors named "F Forget"

Claim this Profile
T
TRYBECA-1: A Randomized Phase III Study of Eryaspase Combined With Chemotherapy Versus Chemotherapy as Second-Line Treatment in Patients With Advanced Pancreatic Adenocarcinoma.
Pascal Hammel, Jean-Philippe Metges, Teresa Macarulla Mercade, Rocio Garcia-Carbonero, Olivier Bouché, Frederic Forget

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab plus sacituzumab govitecan versus avelumab monotherapy as first-line maintenance treatment in patients with advanced urothelial carcinoma: JAVELIN Bladder Medley interim analysis.
J Hoffman-Censits, M Tsiatas, P M-H Chang, M Kim, L Antonuzzo, F Forget

Ann Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic modelling reveals tuna physiological condition is not a driver of floating object association.
Amaël Dupaix, Jean-Louis Deneubourg, Fabien Forget, Mariana Travassos Tolotti, Laurent Dagorn

Proc Biol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breaking barriers: Transoceanic movement by a bull shark.
Ryan Daly, Taryn S Murray, Michael J Roberts, David S Schoeman, Nicolas Lubitz, Fabien Forget

Ecology· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of the therapeutic DNA-based vaccine VB10.16 in combination with atezolizumab in persistent, recurrent or metastatic HPV16-positive cervical cancer: a multicenter, single-arm phase 2a study.
Peter Hillemanns, Michal Zikan, Frédéric Forget, Hannelore G Denys, Jean-Francois Baurain

J Immunother Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis